아시아태평양의 유전자 편집 기술 시장 : 분석 및 예측(2023-2032년)

The Asia-Pacific Gene Editing Technologies Market Expected to Reach $5.05 Billion by 2032

Introduction to Asia-Pacific Gene Editing Technologies Market

The Asia-Pacific gene editing technologies market was valued at $0.49 billion in 2023 and is anticipated to reach $5.05 billion by 2032, witnessing a CAGR of 29.64% during the forecast period 2023-2032. The market for gene editing technologies is expected to grow primarily driven by increasing demand for personalized medicine. Additionally, the introduction of innovative technologies has further accelerated the expansion of this market.

Market Introduction

The Asia-Pacific (APAC) gene editing technologies market is witnessing significant growth fueled by the rising demand for personalized medicine and the introduction of advanced technologies. Gene editing techniques are gaining traction for their potential to customize medical treatments for individual patients, offering more targeted and efficient therapies. Moreover, the emergence of novel gene editing technologies is enhancing precision and efficacy, making them increasingly valuable for both research and clinical applications throughout the APAC region. The area's strong emphasis on scientific research, biotechnology, and supportive regulatory frameworks fosters an environment conducive to the adoption of gene editing technologies. Furthermore, the promotion of ethical and responsible gene editing practices ensures sustainable growth in this market. As gene editing continues to revolutionize healthcare and life sciences, the APAC gene editing technologies market presents promising opportunities for scientific advancement and therapeutic breakthroughs.

Market Segmentation

Segmentation 1: by Technology

• CRISPR Gene Editing Technology
• Non-CRISPR Gene Editing Technology

Segmentation 2: by Application

• Agriculture
• Biomedical

Segmentation 3: by Country

• Japan
• China
• India
• South Korea
• Australia
• Singapore
• Rest-of-Asia-Pacific

How can this report add value to an organization?

Workflow/Innovation Strategy: The gene editing technologies market (by offering) has been segmented into gene editing products and gene editing services. Moreover, the study provides the reader with a detailed understanding of the different applications of gene editing technologies in agricultural and biomedical.

Growth/Marketing Strategy: Gene editing technologies are being used for agricultural, biomedical, and other applications. Various companies are providing gene editing products and services, which is also the key strategy for market players to excel in the current gene editing technologies market.

Competitive Strategy: Key players in the APAC gene editing technologies market have been analyzed and profiled in the study, including manufacturers involved in new product launches, acquisitions, expansions, and strategic collaborations. Moreover, a detailed competitive benchmarking of the players operating in the APAC gene editing technologies market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Table of Contents

Executive Summary

1 Market Scope

• 1.1 Key Questions Answered in the Report

2 Research Methodology

3 Market Overview

• 3.1 Market Overview
• 3.2 Market Footprint and Potential Growth Scenario
  • 3.2.1 Realistic Growth Scenario
  • 3.2.2 Optimistic Growth Scenario
  • 3.2.3 Pessimistic Growth Scenario
• 3.3 Evolution of Gene Editing Technologies
• 3.4 Clinical Trials

4 Industry Outlook

• 4.1 Regulatory Landscape
  • 4.1.1 Legal Requirements and Frameworks in Asia-Pacific
    • 4.1.1.1 Legal Requirements and Framework in Japan
  • 4.1.2 Expedited Regulatory Designations Around the World
• 4.2 Product Benchmarking
  • 4.2.1 Product Benchmarking (by Technology)
  • 4.2.2 Comparative Analysis
• 4.3 Technology Adoption Matrix
• 4.4 Industry Trends
  • 4.4.1 Leveraging Collaboration as a Major Key Strategies to Create Opportunities for Gene Editing Technologies
  • 4.4.2 Growing Focus on Gene Therapies
• 4.5 Patent Analysis
  • 4.5.1 Patent Analysis (by Year)
  • 4.5.2 Patent Analysis (by Technology)
  • 4.5.3 Patent Analysis (by Region)
  • 4.5.4 Patent Analysis (by Country)

5 Gene Editing Technologies Market (by Region), Value ($Million), 2022-2032

• 5.1 Overview
• 5.2 Asia-Pacific
  • 5.2.1 Asia-Pacific Gene Editing Technologies Market (by Application)
  • 5.2.2 Asia-Pacific Gene Editing Technologies Market (by Technology)
  • 5.2.3 Asia-Pacific Gene Editing Technologies Market (by Country)
    • 5.2.3.1 China
      • 5.2.3.1.1 China Gene Editing Technologies Market (by Application)
      • 5.2.3.1.2 China Gene Editing Technologies Market (by Technology)
    • 5.2.3.2 Japan
      • 5.2.3.2.1 Japan Gene Editing Technologies Market (by Application)
      • 5.2.3.2.2 Japan Gene Editing Technologies Market (by Technology)
    • 5.2.3.3 India
      • 5.2.3.3.1 India Gene Editing Technologies Market (by Application)
      • 5.2.3.3.2 India Gene Editing Technologies Market (by Technology)
    • 5.2.3.4 Australia
      • 5.2.3.4.1 Australia Gene Editing Technologies Market (by Application)
      • 5.2.3.4.2 Australia Gene Editing Technologies Market (by Technology)
    • 5.2.3.5 Singapore
      • 5.2.3.5.1 Singapore Gene Editing Technologies Market (by Application)
      • 5.2.3.5.2 Singapore Gene Editing Technologies Market (by Technology)
    • 5.2.3.6 South Korea
      • 5.2.3.6.1 South Korea Gene Editing Technologies Market (by Application)
      • 5.2.3.6.2 South Korea Gene Editing Technologies Market (by Technology)
    • 5.2.3.7 Rest-of-Asia-Pacific
      • 5.2.3.7.1 Rest-of-Asia-Pacific Gene Editing Technologies Market (by Application)
      • 5.2.3.7.2 Rest-of-Asia-Pacific Gene Editing Technologies Market (by Technology)

6 Company Profiles

• 6.1 Takara Bio Inc.
  • 6.1.1 Company Overview
  • 6.1.2 Role of Takara Bio Inc. in the Gene Editing Technologies Market
  • 6.1.3 Major Products: Key Specifications
  • 6.1.4 Key Competitors
  • 6.1.5 Financials
  • 6.1.6 Key Insights about the Financial Health of the Company
  • 6.1.7 Analyst Perspective